view host small investor meet today nyc
cl presid ceo noel wallac svp investor relat
john faucher came away deeper appreci
cultur organiz chang made colgat sinc
take ceo reign wallac catalyst
chang cl execut focu includ pick pace
chang includ faster innov focus stabil
core busi chang compens driven part
organ sale growth leverag technolog drive growth
cost save
improv
begin bear fruit cl organ sale growth improv
fastest growth quarter believ broadli
reflect current valuat cl stock perform
benefit improv fundament flight safeti
ytd vs share trade price-to-earnings
premium xlp/ vs year histor
averag rais price target
reflect cl fundament progress date maintain
market perform rate larg valuat
takeaway meet cl ceo highlight
includ wallac focus improv organ sale growth
via innov premium includ increas pace
innov make bigger innov bet line
extens hint addit relaunch core busi
next year management expect result resumpt
share gain note share progress increasingli difficult
track given expansion/growth non-track channel
management mention differ lever take price off-set
commod inflation/fx includ use revenu growth
manag sophist approach similar ko review
price/pack architectur take analyt approach
cost cl drive growth pressur ep
guidanc remain -msd look forward management
expect hold level invest shift toward
digit roi higher similar playbook cl turn
around hill cl open explor opportun
select believ skin health remain big
focu management note would will lever
right deal
total relaunch proceed expect cl process
relaunch colgat total estim cl sale
product hit shelv feb like expand
global includ total relaunch brazil higher price
relaunch stick cl use packag downsiz
 higher list price rest world colgat
total hold share earli sign repurchas
cycl improv veloc turn
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud restructur charg one-tim item
compani data secur llc estim reuter
addit takeaway meet ceo noel wallac
growth elev cl rebas ep call ep -msd
higher tax rate/fx/commod weigh ep manag also plan big
step ad spend estim y/i support signific relaunch core busi
innov believ stepped-up spend potenti foreshadow multi-year period
increas invest cl want/ne support innov beyond year especi
competitor sit still believ dynam pressur margin could reduc cl
lot ride relaunch ad support cl also call sharp inflect organ sale
growth vs signific driver relaunch
colgat total hill scienc diet franchis cl also introduc innov
adjac natur charcoal toothpast expand distribut new market cl
also take price price secur materi step advertising/promot
support given recent slow-down organ sale growth think cl step
spend much earlier although manag would argu marri increas
spend signific innov fair point also suggest us
innov pipelin slow note faster innov key focu new ceo noel
wallac estim organ sale growth mid-point manag
earli relaunch track relaunch colgat total hill scienc diet
franchis estim total sale respect expect key driver cl
organ sale growth acceler relaunch progress plan product
shelf februari expand global includ total relaunch
brazil manag remain optimist note call late april total sell-through
share last week though note latest track channel
result less robust see page addit cl increas price via downsiz
packag total price per ounc
china struggl expect sequenti improv cl result china remain
challeng step cl taken reorient compani portfolio oral rapidli
premium shift e-commerc cl took signific price china bring
compani products/brand mid-tier premium-ti slowli work way
consum sale declin greater china continu weigh result cl asia pacif segment
manag continu expect sequenti improv growth china though still
neg manag maintain call posit inflect
brazil condit remain challeng volum brazil notabl inflect posit
sale remain weak share loss continu manag note categori trend brazil
appear improv earli day market remain promot brazil key
countri cl largest segment cl hold share toothpast watch close
see sequenti improv continu balanc
price take step back manag reiter stanc price global
reflect broader desir premium portfolio off-set underli cost
includ transact impact fx two-third compani price either
rollov price price accept part compani relaunch
total busi hill scienc diet busi given increment price found odd
pricing/promo slow vs said composit organ
sale growth also balanc cl deliv volum price growth
first time two year volum price y/i four cl categori oral pet
nutrit person look forward manag comment fx spot
rate chang prepar take increment price overal feel good cl abil
implement price expect benefit top-lin margin increas balanc
global share loss continu cl global toothpast share
y/i vs manual toothbrush share vs last
year cl toothpast share manual toothbrush
share share loss also continu key countri includ
brazil china india
compani report secur llc
background total relaunch
total relaunch receiv record brand support cl also take price total one cl
largest brand sale manag character relaunch
biggest news brand year histori manag expect relaunch accomplish
host lofti object includ reinvigor brand drive stepped-up custom engag
increas trial/market share cl support launch record amount market
support includ in-stor display promot influenc super bowl ad accord
manag product advertis test gone extrem well retail commit
extraordinari on-shelf support importantli cl simultan take higher price
relaunch via downsiz packag total price per ounc view part
cl broader push innov premium across portfolio
new formul culmin multi-year process total compet multi-benefit
segment toothpast categori given size/success total manag hesit
chang formula unless truli provid better technolog accord cl new
formul culmin develop hold patent anoth
patent pend new colgat total contain benefit old formul antibacteri
plaqu gingiv caviti whiten tartar enamel protect breath also ad host
new benefit includ anti-sensit instant neutral odor increment enamel
protect new flavor importantli new formula also remov triclosan key ingredi
view posit given controversi surround triclosan think cl
made chang year ago
work minim risk relaunch total relaunch shelf mid-februari
 roll global includ brazil reach global market
manag continu view transit soft launch
replac new total old formul sold time hope minim
risk cl take back old inventori said cl take step minim disrupt
still view execut risk heighten given size brand logist complex
cl wide divers global distribut network
size total
colgat total brand share global higher share sever cl key market
includ share brazil share
 track channel colgat total hold share total brand retail sale
repres cl toothpast sale track channel total sale
slow begin late week end flat
notabl significantli higher price reflect result price/mix
volum last total share also weak last
weak result may also due pullback
promot surround relaunch sale promo last
note grow proport colgat total sale
 non-track channel particularli club mean nielsen result may fulli
repres brand perform
market growth soft past sever quarter cosmet household person
volum price sale growth
sold promo
chart tabl nielsen xaoc includ c-store secur llc
meanwhil toothpast categori remain steadi track channel sinc earli
categori sale growth consist though note rang seen
categori growth deceler late growth slightli better earli
categori sale week end
wk categori promot deceler materi sinc last
cl share toothpast track channel cl overal toothpast sale growth
lag categori result share last
chang bp dollar chang bp sold promo colgate-palmol compani
toothpast volum average price/unit growth
toothpast categori sold promo
chart nielsen xaoc includ c-store secur llc
sale y/yeq sale y/yavg eq price y/i sold promo dollar sharedollar share y/i bp retailperiod end end end end end end procter gambl compani smith kline dwight compani channel data chang bp sold promo cosmet household person
histor track record stabil immun macroeconom volatil cl one
world recogniz consum product compani oral care person care home care
pet nutrit product purchas two-third world household
compani global well ahead ko believ cl well-posit
long-term given unmatch distribut platform across emerg market net sale
per-capita outpac develop market long-stand track record
achiev product save cost effici expect compani fund growth cost-
save program remain import contributor gross margin estim individu
contribut gross margin basi point bp annual next sever year
reflect increasingli streamlin global manufactur footprint continu invest
rigor analyt capabl said cl top-lin growth slow materi past
year particularli emerg market believ cl face macroeconomic
competit pressur across global oper previous result see multi-year
period increas invest cl need step invest improv top-lin trajectori
believ dynam like pressur margin could reduc cl long-term ep growth potenti
view cl histor track record oper stabil favor see dynam
competit environ look forward therefor maintain market perform rate
colgate-palmol compani cl financi guidanc secur llcbonni herzog except per-shar data sourc tabl compani report secur llc estimatesguid provid januari call april call fy fy sale salesflat lsdflat advertisinggross margin bp vs ly bp vs ly bp vs ly bp vs ly growth growth itemstax provid januari call april call juli call octob call fy sale growth lsd-msd sale msd msd lsddown -lsd advertisinggross margin bp vs ly rel absolutelyup rel absolutelyup rel bp vs ly bp vs ly growth adjust ldd around around itemstax end guidancefi guidanc colgate-palmol compani
price target base follow methodolog forward ev-to-ebitda price-to-earnings
analysi absolut rel discount cash flow analysi
forward ev-to-ebitda absolut rel cl current trade ev/ebitda
multipl premium compani histor averag multipl
premium compani histor averag multipl rel peer
cl current trade in-lin hpc peer group discount rel mega-cap peer
forward ev/ebitda multipl basi compar discount hpc/mega-cap
group histor averag forward ev/ebitda basi discount
hpc/mega-cap group histor averag forward ev/ebitda basi price target impli
ev-to-ebitda multipl discount compani current forward
multipl premium premium histor averag forward ev-
to-ebitda multipl believ appropri consid cl recent top-lin margin challeng
elev competit environ key emerg market
forward price-to-earnings absolut rel cl current trade price-to-earnings multipl
premium compani histor averag multipl premium
compani histor averag multipl rel peer cl current trade
premium rel hpc peer group premium rel mega-cap peer
forward price-to-earnings multipl basi compar premium hpc/mega-cap group
year histor averag forward price-to-earnings basi premium hpc/mega-cap group
year histor averag forward price-to-earnings basi price target impli price-to-earnings multipl
discount compani current forward multipl premium
premium histor averag forward price-to-earnings multipl
sum-of-the-part discount also valu cl base sum-of-the-part dcf
analysi appropri valu specif opportun cl differ segment base
analysi believ cl worth north america segment worth europ
segment worth latin america segment worth asia pacif segment worth
africa eurasia segment worth pet nutrit segment worth
chart factset secur llc
factset secur llc
colgate-palmol compani cl quarterli earn secur llcbonni herzog except per-shar data sourc tabl compani report secur llc profit- inc oper ens relat postretir attribut non-control incom minor share eps- eps- per america ex ex america ex pacif ex ex ex net net sale ex ex percent salescost good revenu build unless sale stack organ sale cosmet household person
compani report secur llc estim
segment data net organ sale unless note north salesnorth sale ex-currencynorth sale growthnorth sale growth ex-currencynorth net salesnorth data incomenorth segment net segment ebitnorth ebit marginnorth colgate-palmol compani
cl volum average price/unit growth y/i
cl dollar share y/i chang
chart nielsen xaoc includ c-store secur llc
note nielsen quarter-to-d data repres simpl averag nielsen data period follow last period
compani report nielsen xaoc includ c-store secur llc estim
sale y/yeq sale y/yavg eq price y/i sold promo sold promo y/ydollar sharedollar share y/i bp retailperiod end end end end end end end soap-light combin channel data chang bp dollar quarterli north america segment organ sale performanceconsum take-away retail vs manufactur shipment report nielsenreported/estimatedcorrel
exhibit cl european summari data week end
cl european eq volum average price/eq growth y/i
cl european valu share y/i chang
nielsen esp total europ secur llc
nielsen esp total europ secur llc estim
exhibit cl categori result period end
nielsen scantrack total emerg market secur llc
exhibit cl emerg market valu sale volum average price per growth
nielsen scantrack total emerg market secur llc
note growth rate exclud brazil prior
exhibit cl emerg market valu share y/i chang
nielsen scantrack total emerg market secur llc
price target
price target assum price-to-earnings ev-to-ebitda multipl risk price
target includ increment fx headwind local brand competit materi slowdown emerg
cl one attract geograph profil core hpc stapl view said
weak organ sale growth stepped-up invest spend combin high rel valuat
co base new york new york lead consum product compani
produc market oral care home care person care pet nutrit product compani
signific intern presenc market product countri territori world-wide
brand portfolio includ namesak colgat palmol brand also includ number
global brand includ ajax irish spring hill scienc diet softsoap speed stick suavitel
tom main www colgat com
